Skip to content

Comparison of two drugs given along with local anaesthetic in an ultrasound guided procedure for pain relief in breast surgery

Comparative evaluation of Buprenorphine and dexamethasone as an adjuvant to Ropivacaine for ultrasound guided serratus anterior plane block in breast surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051761
Enrollment
80
Registered
2023-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Buprenorphine and dexamethasone with 0.5% ropivacaine: patients will be observed postoperatively for duration till first analgesic request, total rescue analgesic consumption, pain scor

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients belonging to ASA physical status I and II posted for oncological breast surgery with or without reconstruction with at least 24 hours hospital stay

Exclusion criteria

Exclusion criteria: 1. patient refusal 2. patients with any containdications to regional anaesthesia such as coagulopathy or local infection at the site of injection 3. patients with history of anaphylaxis to local anaesthetics and allergy to study drugs 4. patients with history of underlying psychological disorder 5. patients with chronic systemic illness 6. patients with bleeding diathesis 7. pregnant patients

Design outcomes

Primary

MeasureTime frame
duration of analgesiaTimepoint: from the time of injection of drug in SAP block to the request for first rescue analgesia in PACU till 24 hours

Secondary

MeasureTime frame
1. VAS 2. total postoperative opioid consumptionTimepoint: 1. at PACU,at 2,4,6,8,12,16,20,24 hours 2. at 24 hours postop.

Countries

India

Contacts

Public ContactAnkita

Baba Farid university of Health Sciences Faridkot

jindalseema77@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026